instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial thrombosis'. | Development of intracardiac thrombus in a young patient with antiphospholipid syndrome while she was on rivaroxaban: Case report and literature review.
The probability of right heart thrombus co-existence should be considered in patients with antiphospholipid syndrome (APS) who have pulmonary and cardiac symptoms. The ... | RIVAROXABAN | DrugsGivenReaction | CC BY | 34026171 | 19,531,196 | 2021-05 |
What was the administration route of drug 'RIVAROXABAN'? | Development of intracardiac thrombus in a young patient with antiphospholipid syndrome while she was on rivaroxaban: Case report and literature review.
The probability of right heart thrombus co-existence should be considered in patients with antiphospholipid syndrome (APS) who have pulmonary and cardiac symptoms. The ... | Oral | DrugAdministrationRoute | CC BY | 34026171 | 19,531,196 | 2021-05 |
What was the outcome of reaction 'Atrial thrombosis'? | Development of intracardiac thrombus in a young patient with antiphospholipid syndrome while she was on rivaroxaban: Case report and literature review.
The probability of right heart thrombus co-existence should be considered in patients with antiphospholipid syndrome (APS) who have pulmonary and cardiac symptoms. The ... | Recovering | ReactionOutcome | CC BY | 34026171 | 19,531,196 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Psychiatric care for a person with MELAS syndrome: A case report.
This report provides information for future clinicians who may be involved in treating patients with mitochondrial disorders manifesting with psychiatric problems, as literature in treatment is limited. The interventions focus on both carefully crafted m... | FLUOXETINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34026177 | 19,931,197 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Irritability'. | Psychiatric care for a person with MELAS syndrome: A case report.
This report provides information for future clinicians who may be involved in treating patients with mitochondrial disorders manifesting with psychiatric problems, as literature in treatment is limited. The interventions focus on both carefully crafted m... | FLUOXETINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34026177 | 19,931,197 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sedation'. | Psychiatric care for a person with MELAS syndrome: A case report.
This report provides information for future clinicians who may be involved in treating patients with mitochondrial disorders manifesting with psychiatric problems, as literature in treatment is limited. The interventions focus on both carefully crafted m... | FLUOXETINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34026177 | 19,931,197 | 2021-05 |
What was the dosage of drug 'FLUOXETINE HYDROCHLORIDE'? | Psychiatric care for a person with MELAS syndrome: A case report.
This report provides information for future clinicians who may be involved in treating patients with mitochondrial disorders manifesting with psychiatric problems, as literature in treatment is limited. The interventions focus on both carefully crafted m... | 20 MG, QD | DrugDosageText | CC BY-NC-ND | 34026177 | 19,931,197 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angiocentric lymphoma recurrent'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | GEMCITABINE HYDROCHLORIDE, OXALIPLATIN, PEGASPARGASE | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Confusional state'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | GEMCITABINE HYDROCHLORIDE, OXALIPLATIN, PEGASPARGASE | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | ASPARAGINASE, DEXAMETHASONE, ETOPOSIDE, GEMCITABINE, IFOSFAMIDE, METHOTREXATE, OXALIPLATIN, PEGASPARGASE, PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,967,598 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | ASPARAGINASE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,810,678 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervous system disorder'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | GEMCITABINE HYDROCHLORIDE, OXALIPLATIN, PEGASPARGASE | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | GEMCITABINE HYDROCHLORIDE, OXALIPLATIN, PEGASPARGASE | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin lesion'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | GEMCITABINE HYDROCHLORIDE, OXALIPLATIN, PEGASPARGASE | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | ASPARAGINASE, ETOPOSIDE, IFOSFAMIDE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,809,170 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | ASPARAGINASE, DEXAMETHASONE, ETOPOSIDE, GEMCITABINE, IFOSFAMIDE, METHOTREXATE, OXALIPLATIN, PEGASPARGASE, PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,967,598 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | ASPARAGINASE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 34026185 | 19,948,242 | 2021-05 |
What was the administration route of drug 'METHOTREXATE'? | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | Intrathecal | DrugAdministrationRoute | CC BY-NC-ND | 34026185 | 19,810,678 | 2021-05 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34026185 | 19,944,986 | 2021-05 |
What was the dosage of drug 'GEMCITABINE HYDROCHLORIDE'? | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | UNK, QCY | DrugDosageText | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
What was the dosage of drug 'OXALIPLATIN'? | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | UNK UNK, QCY | DrugDosageText | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
What was the dosage of drug 'PEGASPARGASE'? | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | UNK, QCY | DrugDosageText | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
What was the outcome of reaction 'Angiocentric lymphoma recurrent'? | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | Fatal | ReactionOutcome | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
What was the outcome of reaction 'Skin lesion'? | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | Fatal | ReactionOutcome | CC BY-NC-ND | 34026185 | 19,784,450 | 2021-05 |
What was the outcome of reaction 'Supraventricular tachycardia'? | Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in mos... | Recovered | ReactionOutcome | CC BY-NC-ND | 34026185 | 19,944,986 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | BUSPIRONE HYDROCHLORIDE, DULAGLUTIDE, DULOXETINE, FLECAINIDE, FUROSEMIDE, GLIMEPIRIDE, INSULIN DEGLUDEC, LISINOPRIL, METFORMIN HYDROCHLORIDE, METOPROLOL TARTRATE, POTASSIUM CHLORIDE, RIVAROXABAN | DrugsGivenReaction | CC BY | 34026191 | 19,901,957 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | BUSPIRONE HYDROCHLORIDE, DULOXETINE, FLECAINIDE, FUROSEMIDE, GLIMEPIRIDE, INSULIN DEGLUDEC, LISINOPRIL, METFORMIN HYDROCHLORIDE, METOPROLOL SUCCINATE, RIVAROXABAN | DrugsGivenReaction | CC BY | 34026191 | 19,910,250 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | BUSPIRONE HYDROCHLORIDE, DULOXETINE, FLECAINIDE, FUROSEMIDE, GLIMEPIRIDE, INSULIN DEGLUDEC, LISINOPRIL, METFORMIN HYDROCHLORIDE, METOPROLOL SUCCINATE, RIVAROXABAN | DrugsGivenReaction | CC BY | 34026191 | 19,910,250 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | BUSPIRONE HYDROCHLORIDE, DULOXETINE, FLECAINIDE, FUROSEMIDE, GLIMEPIRIDE, INSULIN DEGLUDEC, LISINOPRIL, METFORMIN HYDROCHLORIDE, METOPROLOL SUCCINATE, RIVAROXABAN | DrugsGivenReaction | CC BY | 34026191 | 19,910,250 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | BUSPIRONE HYDROCHLORIDE, DULOXETINE, FLECAINIDE, FUROSEMIDE, GLIMEPIRIDE, INSULIN DEGLUDEC, LISINOPRIL, METFORMIN HYDROCHLORIDE, METOPROLOL SUCCINATE, RIVAROXABAN | DrugsGivenReaction | CC BY | 34026191 | 19,910,250 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight increased'. | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | BUSPIRONE HYDROCHLORIDE, DULOXETINE, FLECAINIDE, FUROSEMIDE, GLIMEPIRIDE, INSULIN DEGLUDEC, LISINOPRIL, METFORMIN HYDROCHLORIDE, METOPROLOL SUCCINATE, RIVAROXABAN | DrugsGivenReaction | CC BY | 34026191 | 19,910,250 | 2021-05 |
What was the administration route of drug 'DILTIAZEM'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34026191 | 19,995,530 | 2021-05 |
What was the administration route of drug 'DULAGLUTIDE'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | Subcutaneous | DrugAdministrationRoute | CC BY | 34026191 | 19,911,564 | 2021-05 |
What was the dosage of drug 'FLECAINIDE'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | DOUBLED DOSE | DrugDosageText | CC BY | 34026191 | 19,910,250 | 2021-05 |
What was the dosage of drug 'GLIMEPIRIDE'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | 60 mg (milligrams). | DrugDosage | CC BY | 34026191 | 19,901,957 | 2021-05 |
What was the dosage of drug 'METOPROLOL TARTRATE'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | 12.5 µg (micrograms). | DrugDosage | CC BY | 34026191 | 19,901,957 | 2021-05 |
What was the outcome of reaction 'Acute kidney injury'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | Recovered | ReactionOutcome | CC BY | 34026191 | 19,901,957 | 2021-05 |
What was the outcome of reaction 'Bradycardia'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | Recovered | ReactionOutcome | CC BY | 34026191 | 19,911,564 | 2021-05 |
What was the outcome of reaction 'Fatigue'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | Recovered | ReactionOutcome | CC BY | 34026191 | 19,911,564 | 2021-05 |
What was the outcome of reaction 'Hypoglycaemia'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | Recovered | ReactionOutcome | CC BY | 34026191 | 19,910,250 | 2021-05 |
What was the outcome of reaction 'Nausea'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | Recovered | ReactionOutcome | CC BY | 34026191 | 19,911,564 | 2021-05 |
What was the outcome of reaction 'Vomiting'? | Exacerbation of atrial fibrillation related to dulaglutide use.
Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre-existing arrhythmia.
1 INTROD... | Recovered | ReactionOutcome | CC BY | 34026191 | 19,910,250 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | Steroid therapy is effective for IgA nephropathy after liver transplantation in a pediatric patient.
Hepatic IgA nephropathy is a complication of chronic liver disease. IgA nephropathy after liver transplantation is rare, especially in children, and carries a significant risk factor for chronic renal failure and mortal... | PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34026195 | 19,592,188 | 2021-05 |
What was the outcome of reaction 'Cytomegalovirus infection'? | Steroid therapy is effective for IgA nephropathy after liver transplantation in a pediatric patient.
Hepatic IgA nephropathy is a complication of chronic liver disease. IgA nephropathy after liver transplantation is rare, especially in children, and carries a significant risk factor for chronic renal failure and mortal... | Recovered | ReactionOutcome | CC BY-NC-ND | 34026195 | 19,592,188 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | CEFTRIAXONE, DIAZEPAM, METRONIDAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tetanus'. | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | CEFTRIAXONE, DIAZEPAM, METRONIDAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
What is the weight of the patient? | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | 17 kg. | Weight | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
What was the administration route of drug 'CEFTRIAXONE'? | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
What was the administration route of drug 'DIAZEPAM'? | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
What was the administration route of drug 'METRONIDAZOLE'? | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
What was the dosage of drug 'CEFTRIAXONE'? | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | 1 DF TWICE A DAY | DrugDosageText | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
What was the dosage of drug 'METRONIDAZOLE'? | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | 1 DF THREE TIMES A DAY | DrugDosageText | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | Recovering | ReactionOutcome | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
What was the outcome of reaction 'Tetanus'? | Progressive localized tetanus in patient with inadequate human tetanus immunoglobulin therapy.
Localized tetanus is a rare form of tetanus and generally has a better prognosis, but it could become fatal when it progresses into generalized tetanus. Treatment is challenging as there are limited data about clinical manage... | Recovering | ReactionOutcome | CC BY-NC-ND | 34026537 | 19,362,322 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study.
Non-small cell lung cancer (NSCLC) patients with HER2 mutations and amplification may benefit from HER2-targeted therapy, including afatinib. However, the data regarding the clini... | AFATINIB | DrugsGivenReaction | CC BY | 34026634 | 19,403,152 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study.
Non-small cell lung cancer (NSCLC) patients with HER2 mutations and amplification may benefit from HER2-targeted therapy, including afatinib. However, the data regarding the clini... | AFATINIB | DrugsGivenReaction | CC BY | 34026634 | 19,403,152 | 2021 |
What was the dosage of drug 'AFATINIB'? | Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study.
Non-small cell lung cancer (NSCLC) patients with HER2 mutations and amplification may benefit from HER2-targeted therapy, including afatinib. However, the data regarding the clini... | 40 mg (milligrams). | DrugDosage | CC BY | 34026634 | 19,403,152 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature.
Extramedullary multiple myeloma (EMM) is an aggressive sub-entity of multiple myelo... | BORTEZOMIB, DARATUMUMAB, DEXAMETHASONE | DrugsGivenReaction | CC BY | 34026784 | 20,178,711 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature.
Extramedullary multiple myeloma (EMM) is an aggressive sub-entity of multiple myelo... | BORTEZOMIB, DARATUMUMAB, DEXAMETHASONE | DrugsGivenReaction | CC BY | 34026784 | 20,178,711 | 2021 |
What was the dosage of drug 'BORTEZOMIB'? | Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature.
Extramedullary multiple myeloma (EMM) is an aggressive sub-entity of multiple myelo... | UNK (WEEKLY) | DrugDosageText | CC BY | 34026784 | 20,178,711 | 2021 |
What was the dosage of drug 'DARATUMUMAB'? | Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature.
Extramedullary multiple myeloma (EMM) is an aggressive sub-entity of multiple myelo... | UNK (WEEKLY) | DrugDosageText | CC BY | 34026784 | 20,178,711 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature.
Extramedullary multiple myeloma (EMM) is an aggressive sub-entity of multiple myelo... | UNK (WEEKLY) | DrugDosageText | CC BY | 34026784 | 20,178,711 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Lung cancer diagnosed on pap smear: A case report and review of the literature.
•Pap smear test can detect metastases of extragenital malignancies.•Metastases of extragenital cancers to the cervix are predominantly adenocarcinomas.•Immunostaining is critical in determining the primary cancer site.
1 Introduction
The p... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED | DrugsGivenReaction | CC BY | 34026999 | 19,752,953 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Reversible male infertility with valproate use: A review of the literature.
Sodium valproate is a broad spectrum anti-seizure medication useful in the treatment of both generalized and focal epilepsies. The association between valproate and female reproductive disorders is well understood and delineated. Male infertili... | LAMOTRIGINE, LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34027381 | 19,421,257 | 2021 |
What was the dosage of drug 'LAMOTRIGINE'? | Reversible male infertility with valproate use: A review of the literature.
Sodium valproate is a broad spectrum anti-seizure medication useful in the treatment of both generalized and focal epilepsies. The association between valproate and female reproductive disorders is well understood and delineated. Male infertili... | 150 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34027381 | 19,421,257 | 2021 |
What was the dosage of drug 'VALPROIC ACID'? | Reversible male infertility with valproate use: A review of the literature.
Sodium valproate is a broad spectrum anti-seizure medication useful in the treatment of both generalized and focal epilepsies. The association between valproate and female reproductive disorders is well understood and delineated. Male infertili... | 500 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34027381 | 19,421,257 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ischaemic stroke'. | Risk of ischaemic stroke associated with antiepileptic drugs: a population-based case-control study in Catalonia.
BACKGROUND
Cerebrovascular disorders have occurred more frequently in some Central Nervous System (CNS) disorders, such as epilepsy. Some CNS drugs have been associated with increased stroke risk. Our aim w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34030653 | 20,533,613 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Axonal neuropathy'. | Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies.
Anti-glial nuclear antibody (AGNA) is an onconeuroal antibody targeting the nuclei of Bergmann glia in the cerebellum and Anti-SRY-related HMG-box 1 (SOX1). It is highly specifi... | CISPLATIN, ETOPOSIDE, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY | 34030742 | 19,651,914 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral motor neuropathy'. | Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies.
Anti-glial nuclear antibody (AGNA) is an onconeuroal antibody targeting the nuclei of Bergmann glia in the cerebellum and Anti-SRY-related HMG-box 1 (SOX1). It is highly specifi... | CISPLATIN, ETOPOSIDE, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY | 34030742 | 19,651,914 | 2021-05-24 |
What was the outcome of reaction 'Axonal neuropathy'? | Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies.
Anti-glial nuclear antibody (AGNA) is an onconeuroal antibody targeting the nuclei of Bergmann glia in the cerebellum and Anti-SRY-related HMG-box 1 (SOX1). It is highly specifi... | Recovering | ReactionOutcome | CC BY | 34030742 | 19,651,914 | 2021-05-24 |
What was the outcome of reaction 'Peripheral motor neuropathy'? | Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies.
Anti-glial nuclear antibody (AGNA) is an onconeuroal antibody targeting the nuclei of Bergmann glia in the cerebellum and Anti-SRY-related HMG-box 1 (SOX1). It is highly specifi... | Recovering | ReactionOutcome | CC BY | 34030742 | 19,651,914 | 2021-05-24 |
What was the dosage of drug 'PREDNISOLONE'? | Testicular Plasmablastic Lymphoma in an HIV-Negative Patient: A Rare Case Presentation.
Plasmablastic lymphoma (PBL) is a very rare disease and it is usually considered a human immunodeficiency virus (HIV)-related B-cell lymphoma that carries a poor prognosis. It mostly involves the oral cavity, lungs, nasal cavity, ga... | UNK, DA?EPOCH REGIMEN, RECEIVED 2 CYCLES | DrugDosageText | CC BY-NC | 34032157 | 19,818,797 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Testicular Plasmablastic Lymphoma in an HIV-Negative Patient: A Rare Case Presentation.
Plasmablastic lymphoma (PBL) is a very rare disease and it is usually considered a human immunodeficiency virus (HIV)-related B-cell lymphoma that carries a poor prognosis. It mostly involves the oral cavity, lungs, nasal cavity, ga... | DA?EPOCH REGIMEN, RECEIVED 2 CYCLES | DrugDosageText | CC BY-NC | 34032157 | 19,639,942 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | CARBIDOPA\LEVODOPA, CODEINE, DIVALPROEX SODIUM, GABAPENTIN, LAMOTRIGINE, LORAZEPAM, OLANZAPINE, PRAMIPEXOLE, QUETIAPINE FUMARATE, ROPINIROLE, TEMAZEPAM | DrugsGivenReaction | CC BY-NC | 34032164 | 19,460,417 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | CARBIDOPA\LEVODOPA, CODEINE, DIVALPROEX SODIUM, FLUOXETINE HYDROCHLORIDE, GABAPENTIN, LAMOTRIGINE, OLANZAPINE, PRAMIPEXOLE, QUETIAPINE, TEMAZEPAM, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34032164 | 19,483,243 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mania'. | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | CARBIDOPA\LEVODOPA, CODEINE, DIVALPROEX SODIUM, FLUOXETINE HYDROCHLORIDE, GABAPENTIN, LAMOTRIGINE, OLANZAPINE, PRAMIPEXOLE, QUETIAPINE, TEMAZEPAM, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34032164 | 19,483,243 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | CARBIDOPA\LEVODOPA, CODEINE, DIVALPROEX SODIUM, GABAPENTIN, LAMOTRIGINE, LORAZEPAM, OLANZAPINE, PRAMIPEXOLE, QUETIAPINE FUMARATE, ROPINIROLE, TEMAZEPAM | DrugsGivenReaction | CC BY-NC | 34032164 | 19,460,417 | 2021 |
What was the dosage of drug 'OLANZAPINE'? | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | UNK (STOP DATE: JAN-2017) | DrugDosageText | CC BY-NC | 34032164 | 19,460,417 | 2021 |
What was the dosage of drug 'QUETIAPINE FUMARATE'? | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | UNK (STOP DATE: JAN-2017) | DrugDosageText | CC BY-NC | 34032164 | 19,460,417 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | Recovering | ReactionOutcome | CC BY-NC | 34032164 | 19,460,417 | 2021 |
What was the outcome of reaction 'Intentional product misuse'? | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | Recovering | ReactionOutcome | CC BY-NC | 34032164 | 19,443,895 | 2021 |
What was the outcome of reaction 'Restless legs syndrome'? | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | Recovering | ReactionOutcome | CC BY-NC | 34032164 | 19,460,417 | 2021 |
What was the outcome of reaction 'Self-medication'? | Challenges in the Treatment of Restless Legs Syndrome: A Case Report.
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap... | Recovering | ReactionOutcome | CC BY-NC | 34032164 | 19,443,895 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastatic neoplasm'. | Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America.
OBJECTIVE
To describe clinical manifestations and outcomes in patients with eosinophilic granulomatosis with polyangiitis (EGPA) in North America.
METHODS
Analysis of patients aged 18 years or older who f... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC | 34032390 | 19,812,340 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm malignant'. | Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America.
OBJECTIVE
To describe clinical manifestations and outcomes in patients with eosinophilic granulomatosis with polyangiitis (EGPA) in North America.
METHODS
Analysis of patients aged 18 years or older who f... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, METHOTREXATE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC | 34032390 | 19,812,340 | 2021-06 |
What was the outcome of reaction 'Metastatic neoplasm'? | Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America.
OBJECTIVE
To describe clinical manifestations and outcomes in patients with eosinophilic granulomatosis with polyangiitis (EGPA) in North America.
METHODS
Analysis of patients aged 18 years or older who f... | Fatal | ReactionOutcome | CC BY-NC | 34032390 | 19,812,340 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asymptomatic COVID-19'. | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | DOCETAXEL, LOBAPLATIN | DrugsGivenReaction | CC BY | 34032765 | 19,444,710 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | BORIC ACID, DEXTROSE, DOCETAXEL, LOBAPLATIN | DrugsGivenReaction | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | BORIC ACID, DEXTROSE, DOCETAXEL, LOBAPLATIN | DrugsGivenReaction | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immunodeficiency'. | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | DOCETAXEL, LOBAPLATIN | DrugsGivenReaction | CC BY | 34032765 | 19,444,710 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | BORIC ACID, DEXTROSE, DOCETAXEL, LOBAPLATIN | DrugsGivenReaction | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | BORIC ACID, DEXTROSE, DOCETAXEL, LOBAPLATIN | DrugsGivenReaction | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | BORIC ACID, DEXTROSE, DOCETAXEL, LOBAPLATIN | DrugsGivenReaction | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
What was the administration route of drug 'DEXTROSE'? | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | Intravenous drip | DrugAdministrationRoute | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
What was the administration route of drug 'DOCETAXEL'? | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | Intravenous drip | DrugAdministrationRoute | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
What was the administration route of drug 'LOBAPLATIN'? | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | Intravenous drip | DrugAdministrationRoute | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
What was the dosage of drug 'BORIC ACID'? | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | DOCETAXEL WAS INTRAVENOUSLY DRIP 400 MG/M2 PLUS NORMAL SALINE, REPEAT ONCE EVERY TWO WEEKS | DrugDosageText | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
What was the dosage of drug 'DEXTROSE'? | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | LOBAPLATIN WAS INTRAVENOUSLY DRIP 100 MG/M2 PLUS 5% GLUCOSE FOR 2 HOURS | DrugDosageText | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
What was the dosage of drug 'DOCETAXEL'? | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | DOCETAXEL WAS INTRAVENOUSLY DRIP 400 MG/M2 PLUS NORMAL SALINE, REPEAT ONCE EVERY 2 WEEKS | DrugDosageText | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
What was the dosage of drug 'LOBAPLATIN'? | The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a rapidly emerging infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2. Currently, more than 100 million cases of COVID-19... | LOBAPLATIN WAS INTRAVENOUSLY DRIP 100 MG/M2 PLUS 5% GLUCOSE FOR 2 HOURS | DrugDosageText | CC BY | 34032765 | 19,476,645 | 2021-05-28 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.